<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01389713</url>
  </required_header>
  <id_info>
    <org_study_id>clomid re-007</org_study_id>
    <nct_id>NCT01389713</nct_id>
  </id_info>
  <brief_title>Clomifene Citrate as First Line Treatment in in Vitro Fertilization Cycles for Patients With Lower Ovarian Reserve</brief_title>
  <acronym>clomid</acronym>
  <official_title>Patients With Reduced Ovarian Reserve and In Vitro Fertilization (IVF) Cycles. A Randomized Multicentric Comparison of a Protocol With High Doses of Gonadotropins and a Protocol With Clomiphene Citrate Only. Evaluation of Clinical Effectiveness and Economic Issues</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Istituto Clinico Humanitas</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>IRCCS San Raffaele</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Istituti Clinici Zucchi</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Women with compromised ovarian reserve requiring in vitro fertilization (IVF) still represent
      a demanding challenge for clinicians. It has classically been claimed that using higher
      dosages of gonadotropins may overcome the scarce ovarian responsiveness to hyper-simulation
      and increase the chances of success. However, scientific evidence supporting this view is
      scanty and costs are inevitably much higher. In this study, the investigators hypothesized
      that similar chances of pregnancy may be achieved with a mild stimulation using exclusively
      Clomiphene citrate (CC).
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>September 2008</start_date>
  <completion_date type="Actual">December 2010</completion_date>
  <primary_completion_date type="Actual">December 2010</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>live birth rate</measure>
    <time_frame>end of the study (28 months)</time_frame>
    <description>general &quot;Live birth rate&quot; will be recorded at the end of the study when all participants have performed their In vitro Fertilization (IVF) treatment.
Live birth rate per single patients will be recorded 4 weeks after embryo transfer when a intrauterine gestational sac is expected to be seen in case of pregnancy.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>ratio pregnancies/costs</measure>
    <time_frame>end of the study (28 months)</time_frame>
    <description>at the end of the study the number of obtained pregnancies will be divided by the total costs of treatments in two groups. A cost in euros will be therefore estimated for every single pregnancy in both groups.</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">289</enrollment>
  <condition>Infertility</condition>
  <arm_group>
    <arm_group_label>High doses</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Administration of high doses of gonadotrophins to stimulate ovarian follicular growth</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Clomid</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Administration of Clomiphene Citrate to obtain ovarian follicular growth</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Clomifene Citrate</intervention_name>
    <description>3x50 mg die for 5 days from day 3 to day 7 of the menstrual cycle</description>
    <arm_group_label>Clomid</arm_group_label>
    <other_name>clomid</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>GnRH analog and recombinant human FSH</intervention_name>
    <description>daily subcutaneous 0.1 mg decapeptyl from day 1-2 of the menstrual cycle and recombinant human FSH 450 IU/die from day 3.</description>
    <arm_group_label>High doses</arm_group_label>
    <other_name>decapeptyl</other_name>
    <other_name>Gonal-F</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  age 18-42 years

          -  infertility status

          -  Day 3 serum FSH &gt; 12 IU/ml in at least two occasions or previous poor response (â‰¤3
             oocytes retrieved) to hyper-stimulation

        Exclusion Criteria:

          -  contraindications to infertility treatments or pregnancy
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>42 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>guido ragni, md</last_name>
    <role>Principal Investigator</role>
    <affiliation>Fondazione Ca' Granda Ospedale Maggiore Policlinico</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Fondazione Ca' Granda Ospedale Maggiore Policlinico</name>
      <address>
        <city>Milan</city>
        <zip>20122</zip>
        <country>Italy</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Italy</country>
  </location_countries>
  <reference>
    <citation>Heijnen EM, Eijkemans MJ, De Klerk C, Polinder S, Beckers NG, Klinkert ER, Broekmans FJ, Passchier J, Te Velde ER, Macklon NS, Fauser BC. A mild treatment strategy for in-vitro fertilisation: a randomised non-inferiority trial. Lancet. 2007 Mar 3;369(9563):743-9.</citation>
    <PMID>17336650</PMID>
  </reference>
  <reference>
    <citation>Eijkemans MJ, Heijnen EM, de Klerk C, Habbema JD, Fauser BC. Comparison of different treatment strategies in IVF with cumulative live birth over a given period of time as the primary end-point: methodological considerations on a randomized controlled non-inferiority trial. Hum Reprod. 2006 Feb;21(2):344-51. Epub 2005 Oct 20.</citation>
    <PMID>16239317</PMID>
  </reference>
  <verification_date>July 2011</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>July 1, 2011</study_first_submitted>
  <study_first_submitted_qc>July 7, 2011</study_first_submitted_qc>
  <study_first_posted type="Estimate">July 8, 2011</study_first_posted>
  <last_update_submitted>July 11, 2011</last_update_submitted>
  <last_update_submitted_qc>July 11, 2011</last_update_submitted_qc>
  <last_update_posted type="Estimate">July 12, 2011</last_update_posted>
  <responsible_party>
    <name_title>Guido Ragni</name_title>
    <organization>Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico</organization>
  </responsible_party>
  <keyword>ovarian reserve</keyword>
  <keyword>ovarian stimulation</keyword>
  <keyword>clomifene citrate</keyword>
  <keyword>high doses Follicle Stimulating Hormone (FSH)</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Infertility</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Citric Acid</mesh_term>
    <mesh_term>Clomiphene</mesh_term>
    <mesh_term>Enclomiphene</mesh_term>
    <mesh_term>Zuclomiphene</mesh_term>
    <mesh_term>Triptorelin Pamoate</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

